LCM
GRNAW

Lynwood Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Lynwood Capital Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$12K – 166
2021
Q4 		$12K Buy
+10,000
New +$11.4K 0.01% 106

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Lynwood Capital Management's GRNAW Position: Q1 2022 in Review

Lynwood Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q1 2022, closing a stake of 10,000 shares — an estimated $12K sold.

Lynwood Capital Management first reported a position in GRNAW in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 27 funds tracked by Wall St. Rank hold GRNAW as of Q1 2022.

  • Lynwood Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q1 2022 after selling out during the quarter.
  • Lynwood Capital Management sold 10,000 GreenLight Biosciences Holdings, PBC Warrant shares in Q1 2022, an estimated $12K.
  • Lynwood Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q4 2021 and held it in 1 quarter.
  • Lynwood Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $12K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q1 2022.

Based on Lynwood Capital Management's 13F filing for Q1 2022, filed 5 May 2022.